<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34021132</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>21</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects.</ArticleTitle><Pagination><StartPage>3028</StartPage><MedlinePgn>3028</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-021-23187-9</ELocationID><Abstract><AbstractText>Gene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS lead to severe forms of amyotrophic lateral sclerosis (ALS). Cytoplasmic accumulation of FUS is also observed in other diseases, with unknown consequences. Here, we show that cytoplasmic mislocalization of FUS drives behavioral abnormalities in knock-in mice, including locomotor hyperactivity and alterations in social interactions, in the absence of widespread neuronal loss. Mechanistically, we identified a progressive increase in neuronal activity in the frontal cortex of Fus knock-in mice in vivo, associated with altered synaptic gene expression. Synaptic ultrastructural and morphological defects were more pronounced in inhibitory than excitatory synapses and associated with increased synaptosomal levels of FUS and its RNA targets. Thus, cytoplasmic FUS triggers synaptic deficits, which is leading to increased neuronal activity in frontal cortex and causing related behavioral phenotypes. These results indicate that FUS mislocalization may trigger deleterious phenotypes beyond motor neuron impairment in ALS, likely relevant also for other neurodegenerative diseases characterized by FUS mislocalization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Scekic-Zahirovic</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sanjuan-Ruiz</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-0855-277X</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kan</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neuroimmunology, Klinikum der Universit&#xe4;t M&#xfc;nchen, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BioMedical Center, Medical Faculty, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Megat</LastName><ForeName>Salim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rossi</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2356-4269</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieterl&#xe9;</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassel</LastName><ForeName>Raphaelle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, UMR 7364 CNRS, Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamet</LastName><ForeName>Marguerite</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3323-3647</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, Unit&#xe9; mixte de service du CRBS, UMS 038, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesner</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzeplaeff</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, UMR 7364 CNRS, Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demais</LastName><ForeName>Val&#xe9;rie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Plateforme Imagerie In Vitro, CNRS UPS-3156, NeuroP&#xf4;le, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahadevan</LastName><ForeName>Sonu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hembach</LastName><ForeName>Katharina M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-5041-6205</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picchiarelli</LastName><ForeName>Gina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Nibha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard University and MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonucci</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2583-3522</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dirrig-Grosch</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassubek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7106-9270</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasche</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-8844-3583</Identifier><AffiliationInfo><Affiliation>Ulm University Medical Center, Department of Internal Medicine II, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutillier</LastName><ForeName>Anne-Laurence</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-2317-9280</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, UMR 7364 CNRS, Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roselli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9935-6899</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polymenidou</LastName><ForeName>Magdalini</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1271-9445</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagier-Tourenne</LastName><ForeName>Clotilde</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3058-8322</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard University and MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebscher</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5633-8981</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neuroimmunology, Klinikum der Universit&#xe4;t M&#xfc;nchen, Ludwig-Maximilians-University Munich, Munich, Germany. sabine.liebscher@med.uni-muenchen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BioMedical Center, Medical Faculty, Ludwig-Maximilians-University Munich, Munich, Germany. sabine.liebscher@med.uni-muenchen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. sabine.liebscher@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupuis</LastName><ForeName>Luc</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0902-5824</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, Strasbourg, France. ldupuis@unistra.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS108769</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599551">FUS protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055879" MajorTopicYN="N">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34021132</ArticleId><ArticleId IdType="pmc">PMC8140148</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-23187-9</ArticleId><ArticleId IdType="pii">10.1038/s41467-021-23187-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Jr., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Haass C. TDP-43 and FUS: a nuclear affair. Trends Neurosci. 2011;34:339&#x2013;348. doi: 10.1016/j.tins.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2011.05.002</ArticleId><ArticleId IdType="pubmed">21700347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Haass C. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol. Cell Neurosci. 2013;56:475&#x2013;486. doi: 10.1016/j.mcn.2013.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.03.006</ArticleId><ArticleId IdType="pubmed">23557964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Waibel S, Neumann M, Rabe M, Meyer T, Ludolph AC. Novel missense and truncating mutations in FUS/TLS in familial ALS. Neurology. 2010;75:815&#x2013;817. doi: 10.1212/WNL.0b013e3181f07e26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181f07e26</ArticleId><ArticleId IdType="pubmed">20660363</ArticleId></ArticleIdList></Reference><Reference><Citation>Waibel S, et al. Truncating mutations in FUS/TLS give rise to a more aggressive ALS-phenotype than missense mutations: a clinico-genetic study in Germany. Eur. J. Neurol. 2013;20:540&#x2013;546. doi: 10.1111/ene.12031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12031</ArticleId><ArticleId IdType="pubmed">23217123</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35:1077&#x2013;1097. doi: 10.15252/embj.201592559.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592559</ArticleId><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012;31:4258&#x2013;4275. doi: 10.1038/emboj.2012.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.261</ArticleId><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Huey ED, et al. FUS and TDP43 genetic variability in FTD and CBS. Neurobiol. Aging. 2012;33:1016 e9&#x2013;1016 17. doi: 10.1016/j.neurobiolaging.2011.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.08.004</ArticleId><ArticleId IdType="pmc">PMC4489700</ArticleId><ArticleId IdType="pubmed">21943958</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T, et al. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology. 2010;74:366&#x2013;371. doi: 10.1212/WNL.0b013e3181ccc732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ccc732</ArticleId><ArticleId IdType="pubmed">20124201</ArticleId></ArticleIdList></Reference><Reference><Citation>Broustal O, et al. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J. Alzheimers Dis. 2010;22:765&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pubmed">21158017</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair IP, et al. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry. 2010;81:639&#x2013;645. doi: 10.1136/jnnp.2009.194399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.194399</ArticleId><ArticleId IdType="pubmed">19965854</ArticleId></ArticleIdList></Reference><Reference><Citation>Flies CM, Veldink JH. Chorea is a pleiotropic clinical feature of mutated fused-in-sarcoma in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:309&#x2013;311. doi: 10.1080/21678421.2020.1733021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1733021</ArticleId><ArticleId IdType="pubmed">32116048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, et al. Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation. J. Neurol. 2012;259:1039&#x2013;1044. doi: 10.1007/s00415-011-6292-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6292-6</ArticleId><ArticleId IdType="pubmed">22057404</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J, et al. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology. 2010;75:807&#x2013;814. doi: 10.1212/WNL.0b013e3181f07e0c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181f07e0c</ArticleId><ArticleId IdType="pmc">PMC2938970</ArticleId><ArticleId IdType="pubmed">20668259</ArticleId></ArticleIdList></Reference><Reference><Citation>Merner ND, et al. Exome sequencing identifies FUS mutations as a cause of essential tremor. Am. J. Hum. Genet. 2012;91:313&#x2013;319. doi: 10.1016/j.ajhg.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.07.002</ArticleId><ArticleId IdType="pmc">PMC3415547</ArticleId><ArticleId IdType="pubmed">22863194</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142:2572&#x2013;2580. doi: 10.1093/brain/awz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz217</ArticleId><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 2010;67:739&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4376270</ArticleId><ArticleId IdType="pubmed">20517935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaka, K. et al. Characteristic features of FUS inclusions in spinal motor neurons of sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol.79, 370&#x2013;377 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32142134</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, et al. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol. 2011;122:99&#x2013;110. doi: 10.1007/s00401-011-0816-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0816-0</ArticleId><ArticleId IdType="pubmed">21424531</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H, et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 2010;257:747&#x2013;753. doi: 10.1007/s00415-009-5404-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5404-z</ArticleId><ArticleId IdType="pmc">PMC2864899</ArticleId><ArticleId IdType="pubmed">19946779</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, et al. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur. J. Neurol. 2010;17:969&#x2013;975. doi: 10.1111/j.1468-1331.2010.02975.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.02975.x</ArticleId><ArticleId IdType="pmc">PMC2989679</ArticleId><ArticleId IdType="pubmed">20236174</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Calvet M, et al. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Acta Neuropathol. 2016;131:587&#x2013;604. doi: 10.1007/s00401-016-1544-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1544-2</ArticleId><ArticleId IdType="pubmed">26895297</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin H, et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120:33&#x2013;41. doi: 10.1007/s00401-010-0698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0698-6</ArticleId><ArticleId IdType="pmc">PMC2887939</ArticleId><ArticleId IdType="pubmed">20490813</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87&#x2013;98. doi: 10.1007/s00401-011-0838-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0838-7</ArticleId><ArticleId IdType="pmc">PMC3319073</ArticleId><ArticleId IdType="pubmed">21604077</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134:2595&#x2013;2609. doi: 10.1093/brain/awr201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr201</ArticleId><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci. Res. 2010;66:131&#x2013;133. doi: 10.1016/j.neures.2009.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2009.10.004</ArticleId><ArticleId IdType="pubmed">19833157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori S, et al. Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)-binding protein 1 in Huntington&#x2019;s disease. Neuropathology. 2019;39:358&#x2013;367. doi: 10.1111/neup.12600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12600</ArticleId><ArticleId IdType="pubmed">31599037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B, et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012;2:603. doi: 10.1038/srep00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00603</ArticleId><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino Y, et al. FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2015;3:24. doi: 10.1186/s40478-015-0202-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0202-6</ArticleId><ArticleId IdType="pmc">PMC4408580</ArticleId><ArticleId IdType="pubmed">25907258</ArticleId></ArticleIdList></Reference><Reference><Citation>Orozco D, et al. Loss of fused in sarcoma (FUS) promotes pathological Tau splicing. EMBO Rep. 2012;13:759&#x2013;764. doi: 10.1038/embor.2012.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2012.90</ArticleId><ArticleId IdType="pmc">PMC3410390</ArticleId><ArticleId IdType="pubmed">22710833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S, et al. Altered Tau isoform ratio caused by loss of FUS and SFPQ function leads to FTLD-like phenotypes. Cell Rep. 2017;18:1118&#x2013;1131. doi: 10.1016/j.celrep.2017.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.01.013</ArticleId><ArticleId IdType="pubmed">28147269</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoi S, et al. 3&#x2019;UTR length-dependent control of SynGAP isoform alpha2 mRNA by FUS and ELAV-like proteins promotes dendritic spine maturation and cognitive function. Cell Rep. 2017;20:3071&#x2013;3084. doi: 10.1016/j.celrep.2017.08.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.08.100</ArticleId><ArticleId IdType="pubmed">28954225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S, Sobue G. Importance of functional loss of FUS in FTLD/ALS. Front. Mol. Biosci. 2018;5:44. doi: 10.3389/fmolb.2018.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2018.00044</ArticleId><ArticleId IdType="pmc">PMC5943504</ArticleId><ArticleId IdType="pubmed">29774215</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Mackenzie IRA. Review: Neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol. Appl. Neurobiol. 2019;45:19&#x2013;40. doi: 10.1111/nan.12526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12526</ArticleId><ArticleId IdType="pubmed">30357887</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, S. et al. ALS-causative mutations in FUS/TLS confer gain- and loss-of-function by altered association with SMN and U1-snRNP. Nat. Commun.6, 6171 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 2015;6:6171. doi: 10.1038/ncomms7171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7171</ArticleId><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Erauskin J, et al. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018;100:816&#x2013;830 e7. doi: 10.1016/j.neuron.2018.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, et al. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. elife. 2019;8:e40811. doi: 10.7554/eLife.40811.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40811</ArticleId><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoy A, et al. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in &#x2018;FUSDelta14&#x2019; knockin mice. Brain. 2017;140:2797&#x2013;2805. doi: 10.1093/brain/awx248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx248</ArticleId><ArticleId IdType="pmc">PMC5841203</ArticleId><ArticleId IdType="pubmed">29053787</ArticleId></ArticleIdList></Reference><Reference><Citation>So E, et al. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice. Hum. Mol. Genet. 2018;27:463&#x2013;474. doi: 10.1093/hmg/ddx415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx415</ArticleId><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoen M, et al. Super-resolution microscopy reveals presynaptic localization of the ALS/FTD related protein FUS in hippocampal neurons. Front. Cell Neurosci. 2015;9:496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4709451</ArticleId><ArticleId IdType="pubmed">26834559</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli, G. et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat. Neurosci.22, 1793&#x2013;1805 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858880</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande D, et al. Synaptic FUS localization during motoneuron development and its accumulation in human ALS synapses. Front. Cell Neurosci. 2019;13:256. doi: 10.3389/fncel.2019.00256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00256</ArticleId><ArticleId IdType="pmc">PMC6582137</ArticleId><ArticleId IdType="pubmed">31244613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton CF, et al. Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc. Natl Acad. Sci. USA. 2014;111:E4769&#x2013;E4778. doi: 10.1073/pnas.1406162111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1406162111</ArticleId><ArticleId IdType="pmc">PMC4226112</ArticleId><ArticleId IdType="pubmed">25324524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahadevan, S. et al. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS. 10.1038/s41467-021-23188-8. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140117</ArticleId><ArticleId IdType="pubmed">34021139</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankland PW, Bontempi B. The organization of recent and remote memories. Nat. Rev. Neurosci. 2005;6:119&#x2013;130. doi: 10.1038/nrn1607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1607</ArticleId><ArticleId IdType="pubmed">15685217</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4:771&#x2013;780. doi: 10.1016/S1474-4422(05)70223-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70223-4</ArticleId><ArticleId IdType="pubmed">16239184</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386:1672&#x2013;1682. doi: 10.1016/S0140-6736(15)00461-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00461-4</ArticleId><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet O, Hornberger M, Mioshi E, Hodges JR. Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol. 2011;10:162&#x2013;172. doi: 10.1016/S1474-4422(10)70299-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70299-4</ArticleId><ArticleId IdType="pubmed">21147039</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson ED. Mouse models of frontotemporal dementia. Ann. Neurol. 2012;72:837&#x2013;849. doi: 10.1002/ana.23722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23722</ArticleId><ArticleId IdType="pmc">PMC3539234</ArticleId><ArticleId IdType="pubmed">23280835</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom. Bioinform. 2020;2:lqaa078. doi: 10.1093/nargab/lqaa078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nargab/lqaa078</ArticleId><ArticleId IdType="pmc">PMC7518324</ArticleId><ArticleId IdType="pubmed">33015620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojcik SM, et al. A shared vesicular carrier allows synaptic corelease of GABA and glycine. Neuron. 2006;50:575&#x2013;587. doi: 10.1016/j.neuron.2006.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.04.016</ArticleId><ArticleId IdType="pubmed">16701208</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritschy JM, Mohler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 1995;359:154&#x2013;194. doi: 10.1002/cne.903590111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.903590111</ArticleId><ArticleId IdType="pubmed">8557845</ArticleId></ArticleIdList></Reference><Reference><Citation>Choii G, Ko J. Gephyrin: a central GABAergic synapse organizer. Exp. Mol. Med. 2015;47:e158. doi: 10.1038/emm.2015.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2015.5</ArticleId><ArticleId IdType="pubmed">25882190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota Y, Karube F, Nomura M, Kawaguchi Y. The diversity of cortical inhibitory synapses. Front. Neural Circuits. 2016;10:27. doi: 10.3389/fncir.2016.00027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2016.00027</ArticleId><ArticleId IdType="pmc">PMC4842771</ArticleId><ArticleId IdType="pubmed">27199670</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiihashi G, et al. Dendritic homeostasis disruption in a novel frontotemporal dementia mouse model expressing cytoplasmic fused in sarcoma. EBioMedicine. 2017;24:102&#x2013;115. doi: 10.1016/j.ebiom.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.09.005</ArticleId><ArticleId IdType="pmc">PMC5652009</ArticleId><ArticleId IdType="pubmed">28928015</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat. Neurosci. 2018;21:552&#x2013;563. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, et al. Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascon E, et al. Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia. Nat. Med. 2014;20:1444&#x2013;1451. doi: 10.1038/nm.3717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3717</ArticleId><ArticleId IdType="pmc">PMC4257887</ArticleId><ArticleId IdType="pubmed">25401692</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368&#x2013;380. doi: 10.1016/S1474-4422(13)70026-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70026-7</ArticleId><ArticleId IdType="pubmed">23518330</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, et al. The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2018;89:995&#x2013;1002. doi: 10.1136/jnnp-2017-317459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317459</ArticleId><ArticleId IdType="pubmed">29439163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares TP, et al. Ventricular volume expansion in presymptomatic genetic frontotemporal dementia. Neurology. 2019;93:e1699&#x2013;e1706. doi: 10.1212/WNL.0000000000008386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008386</ArticleId><ArticleId IdType="pmc">PMC6946476</ArticleId><ArticleId IdType="pubmed">31578297</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, et al. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology. 2009;72:1843&#x2013;1849. doi: 10.1212/WNL.0b013e3181a71236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a71236</ArticleId><ArticleId IdType="pmc">PMC2690986</ArticleId><ArticleId IdType="pubmed">19470967</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera, A. L., Dadar, M., Collins, D. L., Ducharme, S. &amp; Frontotemporal Lobar Degeneration Neuroimaging Initiative. Deformation based morphometry study of longitudinal MRI changes in behavioral variant frontotemporal dementia. Neuroimage Clin. 24, 102079 (2019)..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6879994</ArticleId><ArticleId IdType="pubmed">31795051</ArticleId></ArticleIdList></Reference><Reference><Citation>Convery RS, et al. Basal forebrain atrophy in frontotemporal dementia. Neuroimage Clin. 2020;26:102210. doi: 10.1016/j.nicl.2020.102210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102210</ArticleId><ArticleId IdType="pmc">PMC7058403</ArticleId><ArticleId IdType="pubmed">32143137</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmeisser MJ, et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature. 2012;486:256&#x2013;260. doi: 10.1038/nature11015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11015</ArticleId><ArticleId IdType="pubmed">22699619</ArticleId></ArticleIdList></Reference><Reference><Citation>Peixoto RT, Wang W, Croney DM, Kozorovitskiy Y, Sabatini BL. Early hyperactivity and precocious maturation of corticostriatal circuits in Shank3B(-/-) mice. Nat. Neurosci. 2016;19:716&#x2013;724. doi: 10.1038/nn.4260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4260</ArticleId><ArticleId IdType="pmc">PMC4846490</ArticleId><ArticleId IdType="pubmed">26928064</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig AM, Banker G, Chang W, McGrath ME, Serpinskaya AS. Clustering of gephyrin at GABAergic but not glutamatergic synapses in cultured rat hippocampal neurons. J. Neurosci. 1996;16:3166&#x2013;3177. doi: 10.1523/JNEUROSCI.16-10-03166.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-10-03166.1996</ArticleId><ArticleId IdType="pmc">PMC6579124</ArticleId><ArticleId IdType="pubmed">8627355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejanovic B, et al. Palmitoylation of gephyrin controls receptor clustering and plasticity of GABAergic synapses. PLoS Biol. 2014;12:e1001908. doi: 10.1371/journal.pbio.1001908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001908</ArticleId><ArticleId IdType="pmc">PMC4099074</ArticleId><ArticleId IdType="pubmed">25025157</ArticleId></ArticleIdList></Reference><Reference><Citation>Tretter V, et al. Molecular basis of the gamma-aminobutyric acid A receptor alpha3 subunit interaction with the clustering protein gephyrin. J. Biol. Chem. 2011;286:37702&#x2013;37711. doi: 10.1074/jbc.M111.291336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.291336</ArticleId><ArticleId IdType="pmc">PMC3199513</ArticleId><ArticleId IdType="pubmed">21880742</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee J, et al. The residence time of GABA(A)Rs at inhibitory synapses is determined by direct binding of the receptor alpha1 subunit to gephyrin. J. Neurosci. 2011;31:14677&#x2013;14687. doi: 10.1523/JNEUROSCI.2001-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2001-11.2011</ArticleId><ArticleId IdType="pmc">PMC3202462</ArticleId><ArticleId IdType="pubmed">21994384</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TW, et al. Regulation of synapse development by Vgat deletion from ErbB4-positive interneurons. J. Neurosci. 2018;38:2533&#x2013;2550. doi: 10.1523/JNEUROSCI.0669-17.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0669-17.2018</ArticleId><ArticleId IdType="pmc">PMC5858595</ArticleId><ArticleId IdType="pubmed">29431653</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghese CM, et al. An isoflurane- and alcohol-insensitive mutant GABA(A) receptor alpha(1) subunit with near-normal apparent affinity for GABA: characterization in heterologous systems and production of knockin mice. J. Pharmacol. Exp. Ther. 2006;319:208&#x2013;218. doi: 10.1124/jpet.106.104406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.106.104406</ArticleId><ArticleId IdType="pubmed">16807363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee BK, et al. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc. Natl Acad. Sci. USA. 2005;102:17154&#x2013;17159. doi: 10.1073/pnas.0508752102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0508752102</ArticleId><ArticleId IdType="pmc">PMC1288020</ArticleId><ArticleId IdType="pubmed">16284244</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell. 2004;119:1013&#x2013;1026. doi: 10.1016/j.cell.2004.11.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.11.035</ArticleId><ArticleId IdType="pmc">PMC2826211</ArticleId><ArticleId IdType="pubmed">15620359</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayton HM, Missler M, Collier DA, Fernandes C. Altered social behaviours in neurexin 1alpha knockout mice resemble core symptoms in neurodevelopmental disorders. PLoS ONE. 2013;8:e67114. doi: 10.1371/journal.pone.0067114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067114</ArticleId><ArticleId IdType="pmc">PMC3696036</ArticleId><ArticleId IdType="pubmed">23840597</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhof TC. Synaptic neurexin complexes: a molecular code for the logic of neural circuits. Cell. 2017;171:745&#x2013;769. doi: 10.1016/j.cell.2017.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.024</ArticleId><ArticleId IdType="pmc">PMC5694349</ArticleId><ArticleId IdType="pubmed">29100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LY, Jiang M, Zhang B, Gokce O, Sudhof TC. Conditional deletion of all neurexins defines diversity of essential synaptic organizer functions for neurexins. Neuron. 2017;94:611&#x2013;625 e4. doi: 10.1016/j.neuron.2017.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.04.011</ArticleId><ArticleId IdType="pmc">PMC5501922</ArticleId><ArticleId IdType="pubmed">28472659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H, et al. TDP-43 accelerates age-dependent degeneration of interneurons. Sci. Rep. 2017;7:14972. doi: 10.1038/s41598-017-14966-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14966-w</ArticleId><ArticleId IdType="pmc">PMC5668320</ArticleId><ArticleId IdType="pubmed">29097807</ArticleId></ArticleIdList></Reference><Reference><Citation>Khademullah CS, et al. Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis. Brain. 2020;143:800&#x2013;810. doi: 10.1093/brain/awaa034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa034</ArticleId><ArticleId IdType="pubmed">32203578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders. Nat. Neurosci. 2016;19:557&#x2013;559. doi: 10.1038/nn.4257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4257</ArticleId><ArticleId IdType="pmc">PMC4811704</ArticleId><ArticleId IdType="pubmed">26900927</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RM, Brizuela M, Blizzard CA, Dickson TC. Reduced excitability and increased neurite complexity of cortical interneurons in a familial mouse model of amyotrophic lateral sclerosis. Front. Cell Neurosci. 2018;12:328. doi: 10.3389/fncel.2018.00328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00328</ArticleId><ArticleId IdType="pmc">PMC6172321</ArticleId><ArticleId IdType="pubmed">30323744</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes ZI, Kan VWY, Ye X, Liebscher S. Exciting complexity: the role of motor circuit elements in ALS pathophysiology. Front. Neurosci. 2020;14:573. doi: 10.3389/fnins.2020.00573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00573</ArticleId><ArticleId IdType="pmc">PMC7311855</ArticleId><ArticleId IdType="pubmed">32625051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, et al. Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J. Neurosci. 2017;37:9037&#x2013;9053. doi: 10.1523/JNEUROSCI.0811-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0811-17.2017</ArticleId><ArticleId IdType="pmc">PMC5597984</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Ozdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat. Rev. Neurol. 2016;12:651&#x2013;661. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L, Mi D, Llorca A, Marin O. Development and functional diversification of cortical interneurons. Neuron. 2018;100:294&#x2013;313. doi: 10.1016/j.neuron.2018.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.10.009</ArticleId><ArticleId IdType="pmc">PMC6290988</ArticleId><ArticleId IdType="pubmed">30359598</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa T, et al. FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization. Nat. Commun. 2015;6:7098. doi: 10.1038/ncomms8098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8098</ArticleId><ArticleId IdType="pmc">PMC4479014</ArticleId><ArticleId IdType="pubmed">25968143</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K, et al. The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J. Cell Biol. 2013;203:737&#x2013;746. doi: 10.1083/jcb.201306058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201306058</ArticleId><ArticleId IdType="pmc">PMC3857475</ArticleId><ArticleId IdType="pubmed">24297750</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau PH, Cosquer B, Jeltsch H, Cassel JC, Mathis C. Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus. 2008;18:610&#x2013;622. doi: 10.1002/hipo.20422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.20422</ArticleId><ArticleId IdType="pubmed">18306300</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould, T. D. Mood and Anxiety Related Phenotypes in Mice (Humana Press, 2009).</Citation></Reference><Reference><Citation>Witt RM, Galligan MM, Despinoy JR, Segal R. Olfactory behavioral testing in the adult mouse. J. Vis. Exp. 2009;23:949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2782999</ArticleId><ArticleId IdType="pubmed">19229182</ArticleId></ArticleIdList></Reference><Reference><Citation>Winslow, J. T. Mouse social recognition and preference. Curr. Protoc. Neurosci. 10.1002/0471142301.ns0816s22 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">18428583</ArticleId></ArticleIdList></Reference><Reference><Citation>Cholvin T, et al. Dorsal hippocampus and medial prefrontal cortex each contribute to the retrieval of a recent spatial memory in rats. Brain Struct. Funct. 2016;221:91&#x2013;102. doi: 10.1007/s00429-014-0894-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-014-0894-6</ArticleId><ArticleId IdType="pubmed">25260556</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TW, et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature. 2013;499:295&#x2013;300. doi: 10.1038/nature12354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12354</ArticleId><ArticleId IdType="pmc">PMC3777791</ArticleId><ArticleId IdType="pubmed">23868258</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebscher S, Keller GB, Goltstein PM, Bonhoeffer T, Hubener M. Selective persistence of sensorimotor mismatch signals in visual cortex of behaving Alzheimer&#x2019;s disease mice. Curr. Biol. 2016;26:956&#x2013;964. doi: 10.1016/j.cub.2016.01.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2016.01.070</ArticleId><ArticleId IdType="pubmed">27020746</ArticleId></ArticleIdList></Reference><Reference><Citation>Dana H, et al. High-performance calcium sensors for imaging activity in neuronal populations and microcompartments. Nat. Methods. 2019;16:649&#x2013;657. doi: 10.1038/s41592-019-0435-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0435-6</ArticleId><ArticleId IdType="pubmed">31209382</ArticleId></ArticleIdList></Reference><Reference><Citation>Paxinos, G. &amp; Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates (Academic Press/Elsevier, 2001).</Citation></Reference><Reference><Citation>Dorgans K, et al. Short-term plasticity at cerebellar granule cell to molecular layer interneuron synapses expands information processing. elife. 2019;8:e41586. doi: 10.7554/eLife.41586.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41586</ArticleId><ArticleId IdType="pmc">PMC6533085</ArticleId><ArticleId IdType="pubmed">31081751</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rossi P, et al. Aberrant accrual of BIN1 near Alzheimer&#x2019;s disease amyloid deposits in transgenic models. Brain Pathol. 2019;29:485&#x2013;501. doi: 10.1111/bpa.12687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12687</ArticleId><ArticleId IdType="pmc">PMC6542723</ArticleId><ArticleId IdType="pubmed">30506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueden CT, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18:529. doi: 10.1186/s12859-017-1934-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1934-z</ArticleId><ArticleId IdType="pmc">PMC5708080</ArticleId><ArticleId IdType="pubmed">29187165</ArticleId></ArticleIdList></Reference><Reference><Citation>Specht CG, et al. Quantitative nanoscopy of inhibitory synapses: counting gephyrin molecules and receptor binding sites. Neuron. 2013;79:308&#x2013;321. doi: 10.1016/j.neuron.2013.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.05.013</ArticleId><ArticleId IdType="pubmed">23889935</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker R, Tiesinga P, Kotter R. The Scalable Brain Atlas: instant web-based access to public brain atlases and related content. Neuroinformatics. 2015;13:353&#x2013;366. doi: 10.1007/s12021-014-9258-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12021-014-9258-x</ArticleId><ArticleId IdType="pmc">PMC4469098</ArticleId><ArticleId IdType="pubmed">25682754</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Orjuela S, Huang R, Hembach KM, Robinson MD, Soneson C. ARMOR: An Automated Reproducible MOdular Workflow for Preprocessing and Differential Analysis of RNA-seq Data. G3 (Bethesda) 2019;9:2089&#x2013;2096. doi: 10.1534/g3.119.400185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.119.400185</ArticleId><ArticleId IdType="pmc">PMC6643886</ArticleId><ArticleId IdType="pubmed">31088905</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. doi: 10.1186/1471-2105-9-559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A, Horvath S. Network neighborhood analysis with the multi-node topological overlap measure. Bioinformatics. 2007;23:222&#x2013;231. doi: 10.1093/bioinformatics/btl581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btl581</ArticleId><ArticleId IdType="pubmed">17110366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ximerakis M, et al. Single-cell transcriptomic profiling of the aging mouse brain. Nat. Neurosci. 2019;22:1696&#x2013;1708. doi: 10.1038/s41593-019-0491-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0491-3</ArticleId><ArticleId IdType="pubmed">31551601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Spijker, S. in Neuroproteomics (ed. Li, K. W.) 23&#x2013;26 (Humana Press, 2011).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>